NL-OMON51360招募中2 期
68Ga-SATO in paediatric neuroblastoma patient; exploratory, safety, non-randomized, open label, comparative study - GAP NBL study* - 68Ga-SATO antagonist in neuroblastoma
Prinses Máxima Centrum voor Kinderoncologie0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 至 17（—）
入选标准
- •- Age 0-18 years
- •- Written informed consent (by legal representative) and assent consent from
- •the patient when applicable
- •- Patients with a clinical suspicion of neuroblastoma who are referred for the
- •first time for conventional M123IBG imaging and patients with known NBL who are
- •referred for for follow-up M123IBG imaging
排除标准
- •- Children with pre-existing severe auto-immune diseases.
- •- Use of therapeutic long-acting somatostatin analogs (e.g. Sandostatin®,
- •Lanreotide®) within the 21 days before the planned infusion of 68Ga-SATO.
- •- Use of diuretics within 24 hours before the planned infusion of 68Ga-SATO.
- •- pregnancy of the patient
研究者
相似试验
招募中
2 期
68Ga-DOTATATE Neuroblastoma Imaging PilotNeuroblastomaNCT04559217Centre de recherche du Centre hospitalier universitaire de Sherbrooke20
进行中（未招募）
不适用
68Ga-DOTANOC as a PET tool to diagnose nueroendocrine tumors - NDStudy of tumor neuroendocrin originEUCTR2010-022975-67-ITAZIENDA U.L.S.S. N.8 DI ASOLO
进行中（未招募）
1 期
Study to optimise the treatment for high risk neuroblastoma patientsEUCTR2006-001489-17-PLJagiellonian University Medical College3,300
Unknown
1 期
Immunotherapy of Neuroblastoma Patients Using a Combination of Anti-GD2 and NK CellsNeuroblastoma RecurrentNCT03242603National University Hospital, Singapore5
已完成
1 期
MGMT Gene Therapy and Chemotherapy for the treatment of Childhood Brain TumoursChildhood Brain TumoursCancer - BrainACTRN12612000535875The Sydney Children's Hospital Network12